KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 62 filers reported holding KITE PHARMA INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $5,736,000 | +7.4% | 31,900 | -38.1% | 0.02% | +9.5% |
| Q2 2017 | $5,343,000 | +38.1% | 51,536 | +4.6% | 0.02% | +31.2% |
| Q1 2017 | $3,869,000 | +64.5% | 49,288 | -6.0% | 0.02% | +60.0% |
| Q4 2016 | $2,352,000 | -12.8% | 52,447 | +8.6% | 0.01% | -9.1% |
| Q3 2016 | $2,697,000 | +45.4% | 48,280 | +30.1% | 0.01% | +37.5% |
| Q2 2016 | $1,855,000 | +22.3% | 37,100 | +13.4% | 0.01% | +14.3% |
| Q1 2016 | $1,517,000 | +4.8% | 32,702 | +39.2% | 0.01% | +16.7% |
| Q4 2015 | $1,447,000 | +1.9% | 23,489 | -7.9% | 0.01% | 0.0% |
| Q3 2015 | $1,420,000 | -51.7% | 25,503 | -47.1% | 0.01% | -50.0% |
| Q2 2015 | $2,938,000 | +53.9% | 48,182 | +45.5% | 0.01% | +50.0% |
| Q1 2015 | $1,909,000 | +132.0% | 33,104 | +132.0% | 0.01% | +100.0% |
| Q4 2014 | $823,000 | +182.8% | 14,272 | +39.8% | 0.00% | +300.0% |
| Q3 2014 | $291,000 | – | 10,206 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $135,991,000 | 55.96% |
| Lamond Capital Partners LLC | 365,900 | $21,101,000 | 13.82% |
| EcoR1 Capital, LLC | 438,400 | $25,283,000 | 12.80% |
| DSAM Partners (London) Ltd | 399,571 | $23,043,000 | 6.08% |
| Silver Rock Financial LLC | 476,563 | $27,483,000 | 5.08% |
| Cormorant Asset Management, LP | 255,000 | $14,706,000 | 2.27% |
| Opaleye Management Inc. | 76,000 | $4,383,000 | 2.22% |
| Ghost Tree Capital, LLC | 60,000 | $3,460,000 | 1.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 110,970 | $6,400,000 | 1.09% |
| PURA VIDA INVESTMENTS, LLC | 44,250 | $2,552,000 | 0.94% |